Top 10 Blue Chip Stocks To Buy Right Now

One of the most difficult aspects of trading is timing the market. Odds are if you have been in the market over the past nine years, most likely you made some money. This bull market began in March of 2009, and 24/7 Wall St. is looking back to see how some major blue chip stocks compared to the broad markets over this time.

Back on March 6, 2009, the S&P 500 bottomed out at 666.79, and from there began perhaps the biggest bull market of the modern era. At the most recent close, the S&P 500 was at 2,677.67, more than quadrupling its bottom nearly nine years ago.

So how does Goldman Sachs Group Inc. (NYSE: GS) compare to the markets over the past nine years?

On an adjusted close basis, Goldman Sachs ended March 6, 2009, at $72.89 a share, or $81.72 on an unadjusted basis. Goldman Sachs most recently closed at $256.78 on an adjusted basis.

Checking the numbers, it’s fairly obvious that Goldman Sachs’s growth over this period has lagged the broad markets, with shares gaining only 250%. If you had invested $1,000 in Goldman Sachs back then, you would have just $3,522.84 as of Thursday’s close.

Top 10 Blue Chip Stocks To Buy Right Now: Smith & Nephew SNATS, Inc.(SNN)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By Max Byerly]

    Smith & Nephew plc (NYSE:SNN) – Investment analysts at Northcoast Research increased their FY2019 earnings per share estimates for Smith & Nephew in a research note issued on Monday, February 11th. Northcoast Research analyst D. Keiser now anticipates that the medical equipment provider will post earnings per share of $2.05 for the year, up from their previous estimate of $1.94. Northcoast Research also issued estimates for Smith & Nephew’s Q4 2019 earnings at $1.13 EPS.

  • [By Benzinga News Desk]

    Weight Watchers (NYSE: WTW) is tipping the scales on Wall Street: Link

    ECONOMIC DATA
    USA Nonfarm Payrolls for Apr 164.0K vs 189.0K Est; Prior 103.0K. Private Payrolls for Apr 168.0K vs 194.0K Est; Prior 102.0K
    Unemployment Rate for Apr 3.90% vs 4.00% Est; Prior 4.10%
    New York Fed President William Dudley is set to speak at 12:45 p.m. ET.
    The Baker Hughes North American rig count report for the latest week is schedule for release at 1:00 p.m. ET.
    Federal Reserve Bank of San Francisco President John Williams will speak at 3:00 p.m. ET.
    Randal Quarles, Vice Chairman for Supervision, is set to speak at 5:30 p.m. ET.
    Dallas Fed President Robert Kaplan will speak at 8:00 p.m. ET.
    Federal Reserve Bank of Atlanta President Raphael Bostic is set to speak at 8:00 p.m. ET.
    Kansas City Fed President Esther George will speak at 8:00 p.m. ET.
    ANALYST RATINGS
    RBC upgraded Benefitfocus (NASDAQ: BNFT) from Sector Perform to Outperform
    Stephens upgraded FMC (NYSE: FMC) from Equal-Weight to Overweight
    RBC downgraded Colfax (NYSE: CFX) from Outperform to Sector Perform
    Deutsche Bank downgraded Smith & Nephew (NYSE: SNN) from Hold to Sell

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

  • [By Joseph Griffin]

    Zimmer Biomet (NYSE: ZBH) and Smith & Nephew (NYSE:SNN) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, valuation and profitability.

Top 10 Blue Chip Stocks To Buy Right Now: Invesco Value Municipal Income Trust(IIM)

Advisors’ Opinion:

  • [By Logan Wallace]

    6 Meridian bought a new position in Invesco Value Municipal Income Trust (NYSE:IIM) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 62,491 shares of the investment management company’s stock, valued at approximately $883,000. 6 Meridian owned about 0.13% of Invesco Value Municipal Income Trust at the end of the most recent quarter.

Top 10 Blue Chip Stocks To Buy Right Now: Mastercard Incorporated(MA)

Advisors’ Opinion:

  • [By ]

    WikiLeaks said it would “call for a global blockade of Coinbase” because it is “an unfit member of the crypto community.” It’s not the first time WikiLeaks has been reprimanded by a financial services provider, though – Mastercard Inc. (MA) and PayPal Holdings Inc. (PYPL) have both restricted WikiLeaks on their platforms.

  • [By Matthew Frankel, Jordan Wathen, and Dan Caplinger]

    With that in mind, here’s why three of our Motley Fool contributors think would-be cryptocurrency investors are better off considering American Express (NYSE:AXP), Discover Financial Services (NYSE:DFS), or Mastercard (NYSE:MA) instead.

  • [By Matthew Cochrane]

    When Mastercard Inc. (NYSE:MA) reported its second-quarter earnings, investors had plenty of reasons to cheer, despite its shares shedding a few percentage points in the days following the quarterly release. In the quarter, net revenue rose to $3.7 billion, a robust 20% increase year over year, and its adjusted earnings per share (EPS) grew to $1.66, an even more impressive 51% increase year over year. While some of these gains should be attributed to new tax laws and recent acquisitions that have yet to be lapped, there is evidence for plenty of organic growth as well.

  • [By Garrett Baldwin]

    Money Morning Special Situation Strategist Tim Melvin provides his latest list of stocks that will help you get rich… and stay rich. Check them out right here.

    Stocks to Watch Today: V, MA, AAPL, GOOGL
    Visa Inc. (NYSE: V) and Mastercard Inc. (NYSE: MA) are under the microscope this morning. Both payment processing giants have signed a settlement agreement over a merchant lawsuit filed back in 2005, but originally settled in 2012 over merchant swiping fees. Visa will pay an additional $600 million to the original settlement. Mastercard will pay an additional $108 million. Although President Trump plans to hit China with new tariffs, at least one company won’t face the full cost: Apple Inc. (NASDAQ: AAPL). According to reports, the Apple Watch is among a list of consumer tech gadgets that will receive exemptions from the latest round of tariffs on imports. Alphabet Inc. (NASDAQ: GOOGL) announced it will install its Android operating system into automobiles manufactured by Nissan, Mitsubishi, and Renault. The operating system – set for distribution in 2021 – will include Google Maps, Google Assistant, and Google Play. The three manufacturers combined sold 10.6 million vehicles in 2017. Look for earnings reports from AutoZone Inc. (NYSE: AZO), General Mills Inc. (NYSE: GIS), Cracker Barrel Old Country Store Inc. (NASDAQ: CBRL), and Apogee Enterprises Inc. (Nasdaq: APOG).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Matthew Cochrane]

    In what is becoming old hat for investors, after Mastercard Inc (NYSE:MA) reported its first-quarter earnings, shares popped on the news even as the rest of the market trended downward. Not only did the payments network beat expectations when it reported its results earlier this month, it also raised its full-year guidance. The jump in share price, of course, was accompanied by another strong performance from the company’s fundamentals.

  • [By Adam Levy]

    A couple of years ago, PayPal started striking deals with payments networks like Visa (NYSE:V) and Mastercard (NYSE:MA). PayPal agreed to allow users to set their default payments to a credit card in exchange for a break on processing fees. There was also the potential for PayPal to increase its in-store presence, but that never really materialized.

Top 10 Blue Chip Stocks To Buy Right Now: Aon Corporation(AON)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on AON (AON)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Aon PLC (NYSE:AON) Director Jeffrey C. Campbell acquired 5,550 shares of the company’s stock in a transaction dated Monday, August 6th. The shares were purchased at an average cost of $143.84 per share, for a total transaction of $798,312.00. Following the purchase, the director now directly owns 7,084 shares in the company, valued at $1,018,962.56. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

  • [By Stephan Byrd]

    US Bancorp DE raised its stake in shares of Aon (NYSE:AON) by 3.0% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 40,448 shares of the financial services provider’s stock after acquiring an additional 1,178 shares during the quarter. US Bancorp DE’s holdings in AON were worth $5,676,000 as of its most recent filing with the SEC.

  • [By Joseph Griffin]

    Zurcher Kantonalbank Zurich Cantonalbank lessened its stake in Aon PLC (NYSE:AON) by 2.7% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 46,895 shares of the financial services provider’s stock after selling 1,313 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in AON were worth $6,433,000 as of its most recent SEC filing.

Top 10 Blue Chip Stocks To Buy Right Now: Liberty Expedia Holdings, Inc. (LEXEA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Tyers Asset Management LLC reduced its holdings in shares of Liberty Expedia Holdings Inc Series A (NASDAQ:LEXEA) by 54.9% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,192 shares of the technology company’s stock after selling 3,892 shares during the quarter. Tyers Asset Management LLC’s holdings in Liberty Expedia Holdings Inc Series A were worth $140,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 10 Blue Chip Stocks To Buy Right Now: DigitalGlobe, Inc(DGI)

Advisors’ Opinion:

Top 10 Blue Chip Stocks To Buy Right Now: Yandex N.V.(YNDX)

Advisors’ Opinion:

  • [By Leo Sun]

    Yandex (NASDAQ:YNDX) owns Russia’s top search engine, but its lead over Alphabet’s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google always had a caveat: Yandex was more popular on desktop PCs, but Google consistently beat Yandex on tablets and smartphones, sparking concerns about Yandex’s mobile growth.

  • [By ]

    U.S. investors often avoid Russian stocks due to the political risks, sanctions, and currency issues associated with the once-hot emerging market. But despite those challenges, there’s one Russian growth stock that doubled over the past two years — Yandex (NASDAQ:YNDX), which created the country’s top search engine.

  • [By Shane Hupp]

    Yandex (NASDAQ: YNDX) and Jianpu Technology (NYSE:JT) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, profitability, risk and earnings.

  • [By Joseph Griffin]

    Model N (NYSE:MODN) and Yandex (NASDAQ:YNDX) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, analyst recommendations, dividends and profitability.

Top 10 Blue Chip Stocks To Buy Right Now: GTx Inc.(GTXI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    GTx, Inc. (NASDAQ:GTXI) insider Jason T. Shackelford sold 9,279 shares of the business’s stock in a transaction dated Wednesday, June 20th. The stock was sold at an average price of $19.01, for a total transaction of $176,393.79. Following the sale, the insider now directly owns 19,453 shares in the company, valued at $369,801.53. The sale was disclosed in a legal filing with the SEC, which is available through this link.

  • [By Maxx Chatsko]

    Shares of GTx (NASDAQ:GTXI) were obliterated today, falling as much as 92.9% by 3 p.m. EDT, after the pharma company announced that its only drug candidate failed a mid-stage clinical trial. Enobosarm, being evaluated as a potential treatment for stress urinary incontinence, did not meet its primary endpoint in a phase 2 trial. 

  • [By Ethan Ryder]

    Ironwood Pharmaceuticals (NASDAQ:IRWD) and GTX (NASDAQ:GTXI) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends.

  • [By Chris Lange]

    GTx Inc. (NASDAQ: GTXI) will present additional data demonstrating duration of response following completion of treatment for its Phase 2 proof-of-concept clinical trial evaluating enobosarm 3 mg in postmenopausal women with stress urinary incontinence at the upcoming 2018 American Urological Association meeting on May 18.

Top 10 Blue Chip Stocks To Buy Right Now: Iteris, Inc.(ITI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Iteris (NASDAQ: ITI) and Napco Security Technologies (NASDAQ:NSSC) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk.

  • [By Lisa Levin] Gainers
    Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results.
    MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58.
    Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82.
    Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82.
    Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69.
    PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42.
    LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results.
    Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results.
    Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37.
    Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Iteris (ITI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Iteris Inc (NASDAQ:ITI) has received an average recommendation of “Buy” from the six analysts that are covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year target price among analysts that have covered the stock in the last year is $9.50.

  • [By Shane Hupp]

    B. Riley set a $9.00 price target on Iteris (NASDAQ:ITI) in a research report sent to investors on Wednesday morning. The brokerage currently has a buy rating on the technology company’s stock. B. Riley also issued estimates for Iteris’ Q4 2018 earnings at ($0.04) EPS, FY2018 earnings at ($0.08) EPS, Q1 2019 earnings at ($0.02) EPS, Q2 2019 earnings at ($0.05) EPS, Q3 2019 earnings at ($0.01) EPS, Q4 2019 earnings at ($0.04) EPS, FY2019 earnings at ($0.11) EPS, FY2020 earnings at $0.16 EPS and FY2021 earnings at $0.52 EPS.

  • [By Stephan Byrd]

    Iteris (NASDAQ: ITI) and UTStarcom (NASDAQ:UTSI) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability and analyst recommendations.

Top 10 Blue Chip Stocks To Buy Right Now: Kaman Corporation(KAMN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Laurion Capital Management LP purchased a new position in shares of Kaman Co. (NYSE:KAMN) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 17,114 shares of the industrial products company’s stock, valued at approximately $1,192,000. Laurion Capital Management LP owned about 0.06% of Kaman as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Kaman (KAMN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Kaman Aircraft (NYSE:KAMN) hit a new 52-week high and low on Wednesday . The stock traded as low as $67.95 and last traded at $68.00, with a volume of 2807 shares traded. The stock had previously closed at $67.07.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Kaman (KAMN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Leave a Reply

Your email address will not be published. Required fields are marked *